Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||
| Cash income from operating activities | -13.32%28.84M | -22.98%33.27M | 12.76%43.19M | 226.97%38.31M | 11.72M |
| Revenue from customers | -13.32%28.84M | -22.98%33.27M | 12.95%43.19M | 235.28%38.24M | --11.41M |
| Other cash income from operating activities | ---- | ---- | ---- | -79.69%62.76K | --308.99K |
| Cash paid | 23.33%-32.12M | 28.63%-41.9M | -9.51%-58.7M | -144.75%-53.61M | -21.9M |
| Payments to suppliers for goods and services | 23.33%-32.12M | 28.63%-41.9M | -8.73%-58.7M | -146.49%-53.99M | ---21.9M |
| Other cash payments from operating activities | ---- | ---- | ---- | --380.77K | ---- |
| Direct interest paid | ---1K | ---- | ---- | ---- | ---- |
| Direct interest received | -31.92%145K | -31.07%213K | 310.95%309K | -19.17%75.19K | --93.02K |
| Direct tax refund paid | ---- | ---- | ---- | ---14.16K | ---- |
| Operating cash flow | 62.66%-3.14M | 44.63%-8.42M | 0.27%-15.2M | -50.99%-15.24M | ---10.09M |
| Investing cash flow | |||||
| Cash flow from continuing investing activities | 54.09%-674K | -120.10%-1.47M | 159.29%7.3M | -1,378.75%-12.32M | -833K |
| Net PPE purchase and sale | -540.00%-32K | 58.33%-5K | 94.52%-12K | -1,659.94%-218.85K | ---12.44K |
| Net intangibles purchas and sale | 56.12%-642K | 45.51%-1.46M | -27.48%-2.69M | -156.67%-2.11M | ---820.57K |
| Net business purchase and sale | ---- | ---- | ---- | --59.44K | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---52.4K | ---- |
| Net other investing changes | ---- | ---- | 200.00%10M | ---10M | ---- |
| Cash from discontinued investing activities | |||||
| Investing cash flow | 54.09%-674K | -120.10%-1.47M | 159.29%7.3M | -1,378.75%-12.32M | ---833K |
| Financing cash flow | |||||
| Cash flow from continuing financing activities | 1,357.32%4.04M | -103.72%-321K | -36.04%8.63M | -52.25%13.49M | 28.25M |
| Net common stock issuance | --4.34M | ---- | -34.84%8.93M | -51.47%13.71M | --28.25M |
| Net other financing activities | 5.92%-302K | -4.90%-321K | -38.57%-306K | ---220.83K | ---- |
| Cash from discontinued financing activities | |||||
| Financing cash flow | 1,357.32%4.04M | -103.72%-321K | -36.04%8.63M | -52.25%13.49M | --28.25M |
| Net cash flow | |||||
| Beginning cash position | -69.63%4.47M | 5.33%14.7M | -50.20%13.96M | 161.88%28.03M | --10.7M |
| Current changes in cash | 102.15%219K | -1,498.08%-10.21M | 105.19%730K | -181.21%-14.07M | --17.32M |
| Effect of exchange rate changes | 62.07%-11K | -307.14%-29K | --14K | ---- | ---- |
| End cash Position | 4.66%4.67M | -69.63%4.47M | 5.33%14.7M | -50.20%13.96M | --28.03M |
| Free cash from | 61.39%-3.82M | 44.77%-9.89M | -1.89%-17.9M | -60.75%-17.57M | ---10.93M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |